Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Celia Tosello Oliveira"'
Autor:
Lorinda Simms, Allen S. Melemed, Jane E. Latz, Hans Wildiers, Robert Paridaens, Celia Tosello Oliveira, Luc Dirix, Herlinde Dumez, Ana Alvarez, A Prové
Publikováno v:
Clinical Breast Cancer. 7:861-866
Background Pemetrexed and epirubicin are each active in patients with advanced/metastatic breast cancer (MBC). This phase I/II study evaluated these drugs as a combination regimen. Patients and Methods Women with locally advanced or MBC were enrolled
Autor:
Donald L. Patrick, Karen Chung, Lesley Fallowfield, Richard De Boer, Ada Braun, Susan D. Mathias, Charles S. Cleeland, Jean-Jacques Body, Yi Qian, Roger Dansey, Roger von Moos, Stefania Salvagni, Mark Clemons, Alison Stopeck, Katia Tonkin, Allan Lipton, Qi Jiang, Celia Tosello Oliveira, Norikazu Masuda
Publikováno v:
Cancer. 119(4)
BACKGROUND: In this study, the authors evaluated the effect of denosumab versus zoledronic acid (ZA) on pain in patients with advanced breast cancer and bone metastases. METHODS: The prevention of pain, reduction in pain interference with daily life
Autor:
Bernhard Heinrich, Salomon M. Stemmer, Barbara Schmalfeldt, Paul Bevan, Nadia Harbeck, Lori J. Goldstein, Lisa Richters, Celia Tosello Oliveira, Sabine Kastner, C. Mala
Publikováno v:
Journal of Clinical Oncology. 31:508-508
508 Background: uPA and its inhibitor PAI-1 play a key role in tumor invasion, metastasis and tumor growth. uPA and PAI-1 are biomarkers validated at highest level of evidence in breast tumors and are recommended for clinical decision making by ASCO.
Autor:
Celia Tosello Oliveira, Eneida de Moraes Marcilio Cerqueira, Gláucia Maria Machado-Santelli, Carlos Alberto Pereira
Publikováno v:
Mutation research. 322(3)
The micronuclei analysis in exfoliated cells of the buccal cavity was employed in the cytogenetic monitoring of nurses handling antineoplastic drugs. The group under study consisted of 25 subjects who showed a marked increase in micronucleated cells
Autor:
Edison Mantovani Barbosa, Nídia Fabrega Donoso, Cynthia Aparecida Bueno T. Osório, Eloá Muniz F. Alves, Fátima Cristina Waldvogel, Célia Tosello Oliveira, João Carlos Sampaio Góes
Publikováno v:
Revista Brasileira de Ginecologia e Obstetrícia, Vol 21, Iss 4, Pp 187-192 (1999)
Objetivo: analisar as alterações histopatológicas provocadas pela ação da quimioterapia neoadjuvante (fluoracil, epirrubicina e ciclofosfamida; FEC -- 4 ciclos) na área tumoral, no tecido mamário adjacente e nos linfonodos homolaterais, em pe
Externí odkaz:
https://doaj.org/article/137b735bb9c14d0d88c99a165114f103